Local Coverage Determination (LCD)

Special EEG Tests

L34521

Expand All | Collapse All
Proposed LCD
Proposed LCDs are works in progress that are available on the Medicare Coverage Database site for public review. Proposed LCDs are not necessarily a reflection of the current policies or practices of the contractor.

Document Note

Note History

Contractor Information

LCD Information

Document Information

Source LCD ID
N/A
LCD ID
L34521
Original ICD-9 LCD ID
Not Applicable
LCD Title
Special EEG Tests
Proposed LCD in Comment Period
N/A
Source Proposed LCD
N/A
Original Effective Date
For services performed on or after 10/01/2015
Revision Effective Date
For services performed on or after 01/08/2019
Revision Ending Date
N/A
Retirement Date
N/A
Notice Period Start Date
N/A
Notice Period End Date
N/A

CPT codes, descriptions, and other data only are copyright 2023 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2023 American Dental Association. All rights reserved.

Copyright © 2024, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

Issue

Issue Description
Issue - Explanation of Change Between Proposed LCD and Final LCD

CMS National Coverage Policy

This LCD supplements but does not replace, modify or supersede existing Medicare applicable National Coverage Determinations (NCDs) or payment policy rules and regulations for Special EEG Tests. Federal statute and subsequent Medicare regulations regarding provision and payment for medical services are lengthy. They are not repeated in this LCD. Neither Medicare payment policy rules nor this LCD replace, modify or supersede applicable state statutes regarding medical practice or other health practice professions acts, definitions and/or scopes of practice. All providers who report services for Medicare payment must fully understand and follow all existing laws, regulations and rules for Medicare payment for Special EEG Tests and must properly submit only valid claims for them. Please review and understand them and apply the medical necessity provisions in the policy within the context of the manual rules. Relevant CMS manual instructions and policies may be found in the following Internet-Only Manuals (IOMs) published on the CMS Web site.

Internet Only Manual (IOM) Citations:

  • CMS IOM Publication 100-02, Medicare Benefit Policy Manual,
    • Chapter 15, Section 80 Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests
  • CMS IOM Publication 100-03, Medicare National Coverage Determinations (NCD) Manual,
    • Chapter 1, Part 2, Section 160.22 Ambulatory EEG Monitoring
  • CMS IOM Publication 100-08, Medicare Program Integrity Manual,
    • Chapter 13, Section 13.5.4 Reasonable and Necessary Provision in an LCD

 Social Security Act (Title XVIII) Standard References:

  • Title XVIII of the Social Security Act, Section 1862(a)(1)(A) states that no Medicare payment shall be made for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury.
  • Title XVIII of the Social Security Act, Section 1862(a)(1)(D). This section excludes payment for services that are investigational or experimental.
  • Title XVIII of the Social Security Act, Section 1862(a)(7). This section excludes routine physical examinations.
  • Title XVIII of the Social Security Act, Section 1833(e) states that no payment shall be made to any provider for any claim that lacks the necessary information to process the claim.

Federal Register References:

  • Code of Federal Regulations (CFR), Title 42, Volume 2, Chapter IV, Part 410.32 Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions and Part 410.33 Independent diagnostic testing facility.

Coverage Guidance

Coverage Indications, Limitations, and/or Medical Necessity

History/Background and/or General Information

An electroencephalogram (EEG) is a diagnostic test that measures the electrical activity of the brain (brainwaves) using highly sensitive recording equipment attached to the scalp by fine electrodes. It is used to diagnose neurological conditions.

EEGs can be recorded by 24-hour ambulatory cassette. Twenty-four hour ambulatory cassette-recorded EEGs offer the ability to record the EEG on a long-term, outpatient basis. Ambulatory or 24-hour electroencephalographic (EEG) monitoring is accomplished by a cassette recorder that continuously records brain wave patterns during 24 hours of a patient's routine daily activities and sleep. The monitoring equipment consists of an electrode set, preamplifiers, and a cassette recorder. The electrodes attach to the scalp, and their leads are connected to a recorder, usually worn on a belt.

For additional information regarding Ambulatory EEG, please refer to CMS IOM Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 2, Section 160.22 Ambulatory EEG Monitoring.

Ambulatory monitoring is not necessary to evaluate most seizures which are usually readily diagnosed by routine EEG studies, patient examination and history. Monitoring for identification and lateralization of cerebral seizure foci by ambulatory or continuous 24-hour Electroencephalogram (EEG) may be necessary in patients where epilepsy is suspected but not confirmed by clinical manifestations or resting EEG. Ambulatory EEG should always be preceded by an awake and sleep study. The combination of electroencephalographic and video monitoring of a patient is useful and medically necessary in the initial diagnosis of epilepsy, particularly where previous attempts to define or characterize the seizure activity have proven inconclusive. Beyond the initial diagnosis of epilepsy the combination is useful in uncharacterized events, confirmation and/or differentiation between epileptic and non-epileptic.

Ambulatory EEG may also be medically necessary in the differentiation of psychogenic seizures from epilepsy and in the localization of a seizure focus prior to a surgical intervention for intractable epilepsy. It is anticipated that clinical examination and routine electroencephalographic studies be utilized before employing electroencephalographic and video monitoring, and that this study be essential to the establishment of an appropriate treatment regimen. 

Additionally, the study may be used in pediatric beneficiaries where history and clinical descriptions of seizure activity are difficult to obtain. It is anticipated that many of these outpatient studies will not provide the diagnosis within the first 24 hours, but expects that 72 hours of monitoring will be diagnostic in most circumstances. Occasionally patients may require more extensive monitoring, and medical necessity must be documented for review in these circumstances. This 72-hour limitation does not apply to the inpatient setting where patients are frequently withdrawn from their anti-epileptic regimens, and where precise presurgical localization of epileptic foci is often conducted.

It is anticipated that once the diagnosis has been established, this study will not be repeated, nor will it be used in the monitoring of a therapeutic regimen. Again, this expectation will not be applied to patients readmitted for inpatient care of their seizure disorder.

Additionally, ambulatory EEG monitoring may facilitate the differential diagnosis between seizures and syncopal attacks, sleep apnea, cardiac arrhythmias or hysterical episodes. The test may also allow the investigator to identify the epileptic nature of some episodic periods of disturbed consciousness, mild confusion, or peculiar behavior, where resting EEG is not conclusive. It may also allow an estimate of seizure frequency, which may at times help to evaluate the effectiveness of a drug and determine its appropriate dosage.

Digital analysis of an electroencephalogram (EEG) is used to diagnose neurological conditions when routine EEG outcomes and neurological imaging are inconclusive to confirm diagnostic symptoms. Digital analysis of an electroencephalogram (EEG) requires the analysis of an EEG using quantitative analytical techniques such as data selection, quantitative software processing, and dipole source analysis.

Covered Indications

Covered Indications for monitoring for identification and lateralization or localization of cerebral seizure focus

  • Inconclusive EEGs;
  • Experiencing episodic events where you suspect epilepsy but the history, examination, and routine EEG do not resolve the diagnosis uncertainties;
  • Patients with confirmed epilepsy who are experiencing suspected non-epileptic events or for classification of seizure type (only ictal recordings can reliably be used to classify seizure type [or types] which is important in selecting appropriate anti-epileptic drug therapy);
  • Differentiating between neurological and cardiac related problems;
  • Adjusting anti-epileptic medication levels;
  • Localizing seizure focus for enhanced patient management;
  • Identifying and medicating absence seizures;
  • For suspected seizures of sleep disturbances;
  • Seizures which are precipitated by naturally occurring cyclic events or environmental stimuli which are not reproducible in the hospital or clinic setting.

Covered Indications for digital analysis of an electroencephalogram (EEG)

Digital analysis of an electroencephalogram (EEG) meets the definition of medical necessity when performed as an adjunct to traditional EEG for the following conditions:

 Epilepsy, when ANY of the following are met:

  • The long-term EEG is inconclusive and additional testing for possible epileptic spikes or seizures is needed;
  • For topographic voltage and dipole analysis in presurgical candidates with intractable epilepsy.

Cerebral vascular disease:

  • When routine EEG outcomes and neurological imaging are inconclusive to confirm diagnostic symptoms.

Limitations

Limitations for monitoring for identification and lateralization or localization of cerebral seizure focus

The following indications are not covered as they are not considered medically reasonable and necessary:

  • Study of neonates or unattended, non-cooperative patients;
  • Localization of seizure focus/foci when the seizure symptoms and/or other EEG recordings indicate the presence of bilateral foci or rapid generalization; and
  • Final evaluation of patients being considered as candidates for respective surgery.

Electroencephalographic (EEG) video monitoring is medically necessary when the diagnosis cannot be made by neurological examination, standard EEG studies, and ambulatory EEG monitoring, and non-neurological causes of symptoms (e.g., syncope, cardiac arrhythmias) have been ruled out.

Video recording with EEG is usually an inpatient procedure. Inpatient setting is required when stopping medications for pre-surgical planning.

Monitoring beyond 72 hours must be supported by written documentation for each additional 24 hours of monitoring and be made available upon request.

It would not be expected to see more than three services (three of one or three of any combination of services) billed in most circumstances within a one-year period. It is anticipated that once the diagnosis has been established, this study will not be repeated, nor will it be used in the monitoring of a therapeutic regimen (this expectation will not be applied to patients readmitted for inpatient care of their seizure disorder or characterization of seizure changes in any setting). 

The following items represent the number of 24-hour segments of recordings for testing:

  • For diagnostic testing: 2-3 days is usually sufficient when looking for seizures or interictal activity.
  • For pre-surgical evaluation: 7-10 days to capture at least 3 or 4 seizures may be required in order to be sure of seizure onset location reliability. For follow-up, 2-3 days is usually sufficient.

Limitations for digital analysis of electroencephalogram (EEG)

The following indications are not covered as they are not considered medically reasonable and necessary:

  • Anxiety
  • Attention deficit disorder
  • Attention-deficit hyperactivity disorder
  • Autism spectrum disorders
  • Depression
  • Learning disorders
  • Schizophrenia
  • Substance abuse.

It is not routinely appropriate to perform and report digital analysis of EEG when there are no spikes to analyze (eg, when the video –EEG monitoring is normal). If digital analysis of an electroencephalogram (EEG) is reported for reasons other than three- dimensional spike analysis, the patient’s record must clearly reflect why the digital analysis was needed and address how it assisted with the reading of the data. Digital analysis requires that the neurologist or technician conduct the analysis using quantitative analytical techniques such as data selection, quantitative software processing, and dipole source analysis. Evidence of such analysis should be evident in the medical record (typically, three-dimensional spike localization).

Digital analysis of electroencephalogram (EEG) is reported when substantial additional digital analysis was medically necessary and was performed, such as 3D dipole localization.

Digital analysis would be more commonly used at specialty centers, e.g. epilepsy surgery programs. Note that the codes for "monitoring for identification and lateralization of cerebral seizure focus" already include epileptic spike analysis.

As published in the CMS IOM Publication 100-08, Medicare Program Integrity Manual, Chapter 13, Section 13.5.4, an item or service may be covered by a contractor LCD if it is reasonable and necessary under the Social Security Act Section 1862 (a)(1)(A). Contractors shall determine and describe the circumstances under which the item or service is considered reasonable and necessary.

Provider Qualifications

A qualified physician for this service/procedure is defined as follows: A) Physician properly enrolled in Medicare. B) Training and expertise must have been acquired within the framework of an accredited residency and/or fellowship program in the applicable specialty/subspecialty in the United States or must reflect equivalent education, training, and expertise endorsed by an academic institution in the United States and/or by the applicable specialty/subspecialty society in the United States.

The accuracy of non-invasive diagnostic studies depends on the knowledge, skill and experience of the technologist and the physician performing the supervision and/or interpretation of the study. Consequently, the technologist and the physician must maintain proof of training and experience. All non-invasive diagnostic studies must be: (1) performed by a qualified physician, or (2) performed under the general supervision of a qualified physician in the office setting. For EEG studies performed in a IDTF setting, the supervising physician must be a Board Certified (ABMS) Neurologist, and the technician qualification must include credentialing by ABRET Neurodiagnostic Credentialing and Accreditation for Registered Electroencephalographic Technologist (R. EEG T.).

Summary of Evidence

N/A

Analysis of Evidence (Rationale for Determination)

N/A

Proposed Process Information

Synopsis of Changes
Changes Fields Changed
N/A
Associated Information
Sources of Information
Bibliography
Open Meetings
Meeting Date Meeting States Meeting Information
N/A
Contractor Advisory Committee (CAC) Meetings
Meeting Date Meeting States Meeting Information
N/A
MAC Meeting Information URLs
N/A
Proposed LCD Posting Date
Comment Period Start Date
Comment Period End Date
Reason for Proposed LCD
Requestor Information
This request was MAC initiated.
Requestor Name Requestor Letter
View Letter
N/A
Contact for Comments on Proposed LCD

Coding Information

Bill Type Codes

Code Description

Please accept the License to see the codes.

N/A

Revenue Codes

Code Description

Please accept the License to see the codes.

N/A

CPT/HCPCS Codes

Please accept the License to see the codes.

N/A

ICD-10-CM Codes that Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

Additional ICD-10 Information

General Information

Associated Information

Documentation Requirements

Please refer to the Local Coverage Article: Billing and Coding: Special EEG Tests (A57667) for documentation requirements that apply to the reasonable and necessary provisions outlined in this LCD.

Utilization Guidelines

Please refer to the Local Coverage Article: Billing and Coding: Special EEG Tests (A57667) for utilization guidelines that apply to the reasonable and necessary provisions outlined in this LCD.

Sources of Information

Aetna Clinical Policy Bulletin- Ambulatory Electroencephalography, Number 0425 (2012)

Aetna Clinical Policy Bulleting- Electroencephalographic (EEG) Video Monitoring, Number 0322 (2012)

Agency for Healthcare Research and Quality (AHRQ) National Guidelines Clearinghouse Guideline Summary NGC- 8451: ACR Appropriateness Criteria® seizures and epilepsy. (2011).

Agency for Healthcare Research and Quality (AHRQ) National Guidelines Clearinghouse Guideline Summary NGC- 8696: Care of the patient with seizures. Second edition. (2009).

Agency for Healthcare Research and Quality (AHRQ) National Guidelines Clearinghouse Guideline Summary NGC- 8985: The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. (2012).

Agency for Healthcare Research and Quality (AHRQ) National Guidelines Clearinghouse Guideline Summary NGC- 6747: Practice parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. (2007).

American Academy of Neurology, Coding FAQs (2012)

“EEG – 24 Hour Monitoring,” National Government Services, Inc. LCD, (13102) L32963.

“EEG – 24 Hour Monitoring,” NHIC, Corp. LCD, (14502) L29878.

Florida Blue Medical Coverage Guidelines, 01-95805-13, Evoked Potentials, Intraoperative Neurophysiologic Testing, and Quantitative Electroencephalography (QEEG).

“Special Electroencephalography (EEG),” Novitas Solutions, Inc. LCD, (07102) L32717.

Bibliography

N/A

Revision History Information

Revision History Date Revision History Number Revision History Explanation Reasons for Change
01/08/2019 R1

Revision Number: 1
Publication: November 2019 Connection
LCR A/B2019-075

Explanation of Revision: Based on Change Request (CR) 10901, the LCD was revised to remove all billing and coding and all language not related to reasonable and necessary provisions (“Bill Type Codes,” “Revenue Codes,” “CPT/HCPCS Codes,” “ICD-10 Codes that Support Medical Necessity,” “Documentation Requirements” and “Utilization Guidelines” sections of the LCD) and place them into a newly created billing and coding article. During the process of moving the ICD-10-CM diagnosis codes to the billing and coding article, the ICD-10-CM diagnosis code ranges were broken out and listed individually. In addition, the Social Security Act, Code of Federal Regulations (CFR), and Internet Only Manuals (IOM) references were updated. Also, IOM language was removed and instead the applicable manual reference was listed. The effective date of this revision is for claims processed on or after January 8, 2019, for dates of service on or after October 3, 2018.

At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination and therefore not all the fields included on the LCD are applicable as noted in this LCD.

  • Other (Revision based on CR10901)
N/A

Associated Documents

Attachments
N/A
Related Local Coverage Documents
Articles
A57667 - Billing and Coding: Special EEG Tests
Related National Coverage Documents
N/A
Public Versions
Updated On Effective Dates Status
11/21/2019 01/08/2019 - N/A Currently in Effect You are here
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them.

Keywords

N/A

Read the LCD Disclaimer